A new study in Nutrients finds that children with autism have gut bacteria similar to those of their family members.

As Japan faces a caregiver shortage, a new survey shows that trust, not age, shapes willingness to adopt home-care robots and share health data.

Early exposure to online gaming significantly increases the risk of gaming addiction, emotional distress, and physical health ...

Landmark biomechanical study shows AxioMed's viscoelastic lumbar disc is the first implant to replicate the natural mechanical behaviors of a human disc, unlocking a new era of motion-preserving spine ...

For those seeking to lessen anxiety, treat depression or enhance cognitive functioning without medication, a groundbreaking technology is now available at Viva Infusions & Wellness, a health and ...

As the Senate Finance Committee prepares for its November 19 hearing, "The Rising Cost of Health Care: Considering Meaningful Solutions for All Americans," Consumer Action for a Strong Economy (CASE) ...

Pay It Forward campaign: the American Foundation for Suicide Prevention (AFSP). Continuing the tradition of supporting meaningful causes, PAR will make a donation on behalf of its customers to AFSP, ...

ONCOassist®, the world's leading oncology decision-support platform used by more than 100,000 oncology professionals across 180 countries, has announced the launch of ONCO-IQ, a new quiz-based ...

Honest Medical, a rapidly expanding ecommerce provider of essential healthcare supplies, today announced a donation of over $10,000 worth of disposable basic needs products to the San Diego Food Bank.

Mount Sinai Medical Center has achieved HIMSS Electronic Medical Record Adoption Model (EMRAM) Stage 7 validation, the highest level of digital health maturity recognized by the Healthcare Information ...

Alafair Biosciences, Inc., a medical device company redefining soft-tissue protection in orthopedic surgery, announced today the first clinical use of its VersaCoat™ Flowable Hydrogel (VersaCoat™ ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer's Disease (CTAD) conference, being held in ...